Literature DB >> 27595464

Pulmonary arterial hypertension: Basic knowledge for clinicians.

Diana Santos-Ribeiro1, Pedro Mendes-Ferreira1, Carolina Maia-Rocha1, Rui Adão1, Adelino F Leite-Moreira1, Carmen Brás-Silva2.   

Abstract

Pulmonary arterial hypertension is a progressive syndrome based on diverse aetiologies, which is characterized by a persistent increase in pulmonary vascular resistance and overload of the right ventricle, leading to heart failure and death. Currently, none of the available treatments is able to cure pulmonary arterial hypertension; additional research is therefore needed to unravel the associated pathophysiological mechanisms. This review summarizes current knowledge related to this disorder, and the several experimental animal models that can mimic pulmonary arterial hypertension and are available for translational research.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hypertension artérielle pulmonaire (HTAP); Insuffisance ventriculaire droite; Mécanismes physiopathologiques et modèles expérimentaux de l’HTAP; Pathophysiological mechanisms; Pulmonary arterial hypertension; Pulmonary arterial hypertension experimental models; Right ventricular failure

Mesh:

Year:  2016        PMID: 27595464     DOI: 10.1016/j.acvd.2016.03.004

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  13 in total

1.  Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.

Authors:  Cui Zhai; Nana Zhang; Jian Wang; Meng Cao; Jing Luan; Huan Liu; Qianqian Zhang; Yanting Zhu; Yuxin Xue; Shaojun Li
Journal:  Lung       Date:  2022-09-15       Impact factor: 3.777

Review 2.  The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension.

Authors:  Meng-Chien Willie Hsieh; Wei-Ting Wang; Jwu-Lai Yeh; Chuang-Yu Lin; Yur-Ren Kuo; Su-Shin Lee; Ming-Feng Hou; Yi-Chia Wu
Journal:  Biomedicines       Date:  2022-06-15

3.  Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease.

Authors:  Hee-Jeong Hong; Ye-In Oh; Su-Min Park; Ju-Hyun An; Tae-Hee Kim; Hyung-Kyu Chae; Kyoung-Won Seo; Hwa-Young Youn
Journal:  BMC Vet Res       Date:  2022-07-05       Impact factor: 2.792

Review 4.  Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.

Authors:  Joana Santos-Gomes; Hélène Le Ribeuz; Carmen Brás-Silva; Fabrice Antigny; Rui Adão
Journal:  Biomolecules       Date:  2022-03-22

5.  Lipopolysaccharide acutely suppresses right-ventricular strain in rats with pulmonary artery hypertension.

Authors:  Junjie Zhang; Yanan Cao; Xiaowei Gao; Maoen Zhu; Zhong Zhang; Yue Yang; Qulian Guo; Yonggang Peng; E Wang
Journal:  Pulm Circ       Date:  2017-12-18       Impact factor: 3.017

6.  Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19.

Authors:  Reinis Vilskersts; Dana Kigitovica; Stanislava Korzh; Melita Videja; Karlis Vilks; Helena Cirule; Andris Skride; Marina Makrecka-Kuka; Edgars Liepinsh; Maija Dambrova
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

7.  Simvastatin protects heart function and myocardial energy metabolism in pulmonary arterial hypertension induced right heart failure.

Authors:  Bi Tang; Pinfang Kang; Lei Zhu; Ling Xuan; Hongju Wang; Heng Zhang; Xiaojing Wang; Jiali Xu
Journal:  J Bioenerg Biomembr       Date:  2021-01-04       Impact factor: 2.945

8.  eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.

Authors:  Linya Guo; Yanbing Li; Ying Tian; Shaoxin Gong; Xi Chen; Tianhong Peng; Aiping Wang; Zhisheng Jiang
Journal:  Drug Des Devel Ther       Date:  2019-08-13       Impact factor: 4.162

Review 9.  Endoplasmic reticulum stress and pulmonary hypertension.

Authors:  Yanan Hu; Wenhao Yang; Liang Xie; Tao Liu; Hanmin Liu; Bin Liu
Journal:  Pulm Circ       Date:  2020-02-04       Impact factor: 3.017

10.  Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension.

Authors:  Judith Bernal-Ramírez; Christian Silva-Platas; Carlos Jerjes-Sánchez; Martín R Ramos-González; Eduardo Vázquez-Garza; Héctor Chapoy-Villanueva; Alicia Ramírez-Rivera; Ángel Zarain-Herzberg; Noemi García; Gerardo García-Rivas
Journal:  Oxid Med Cell Longev       Date:  2021-06-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.